Shiu-wen Huang
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
The natural coumarin 7-methoxy-8-isopentenyloxycoumarin alleviates LPS-induced inflammation by suppressing NF-κB and the MAPK/AP-1 pathways and accelerating COX-2 proteasomal degradation.
Journal: European journal of pharmacology
Published: January 23, 2026
Nstpbp5185, a novel benzimidazole derivative, suppresses PDGF signaling and reduces neointimal hyperplasia following vascular injury.
Journal: European journal of pharmacology
Published: November 11, 2025
Aspartame and asthma: immunomodulatory effects on airway inflammation.
Journal: Respiratory research
Published: October 30, 2025
Harnessing engineered mesenchymal stem cell-derived extracellular vesicles for innovative cancer treatments.
Journal: Stem cell research & therapy
Published: August 08, 2025
The hydroxamate based HDAC inhibitor WMJ-J-09 induces colorectal cancer cell death by targeting tubulin and downregulating survivin.
Journal: Scientific reports
Published: February 13, 2025
Association Between Lichen Planus and Atherosclerosis: A Systematic Review and Meta-Analysis.
Journal: Journal of cutaneous medicine and surgery
Published: October 25, 2024
IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment.
Journal: Journal of biomedical science
Published: October 16, 2024
Association of lichen planopilaris with cardiovascular and metabolic disorders: a systematic review and meta-analysis.
Journal: Clinical and experimental dermatology
Published: September 13, 2024
A sensitive post-column derivatization approach for enhancing hydroxyl metabolites detection.
Journal: Analytica chimica acta
Published: August 20, 2024
CCN1 Is a Therapeutic Target for Reperfused Ischemic Brain Injury.
Journal: Translational stroke research
Published: February 27, 2024
Suppression of lipopolysaccharide-induced COX-2 expression via p38MAPK, JNK, and C/EBPβ phosphorylation inhibition by furomagydarin A, a benzofuran glycoside from Magydaris pastinacea.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: December 07, 2023
Last Updated: 09/26/2026